GnRHa protects the ovarian reserve by reducing endoplasmic reticulum stress during cyclophosphamide-based chemotherapy
Abstract Chemotherapy-induced ovarian dysfunction is a serious adverse effect in premenopausal patients with cancer. Gonadotrophin-releasing hormone analogs (GnRHa) protect ovarian function, but its molecular mechanisms have not yet been determined. In this study, we attempted to determine the previ...
Guardado en:
Autores principales: | Xiaolin Li, Sixuan Liu, Xuan Chen, Run Huang, Lisi Ma, Huaiyu Weng, Yang Yu, Xiangyun Zong |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f42003b8ee944e89ba1d69d78f71cb5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An alternative pathway for membrane protein biogenesis at the endoplasmic reticulum
por: Sarah O’Keefe, et al.
Publicado: (2021) -
The use of GnRH analogs in preserving ovarian function during chemotherapy
por: Omar M. Odeh, et al.
Publicado: (2021) -
Endoplasmic Reticulum-Mitochondria Contacts: A Potential Therapy Target for Cardiovascular Remodeling-Associated Diseases
por: Yu Wang, et al.
Publicado: (2021) -
Clinicopathological significance of endoplasmic reticulum stress proteins in ovarian carcinoma
por: Soma Samanta, et al.
Publicado: (2020) -
The flexibility and dynamics of the tubules in the endoplasmic reticulum
por: Pantelis Georgiades, et al.
Publicado: (2017)